arBtrage CAPITALIZING MARKETS — checking… Sign in Sign up
Calendar /

Fortress Biotech, Inc.

FBIO Health Care Biotechnology: Pharmaceutical Preparations
$1.95
▲ +0.5% Today
as of Oct 23, 14:17 ET
Last 30 days -22.92% Sep 14 → Oct 23
$1.82 $2.01 $2.20 $2.39 $2.58 Sep 14 Sep 22 Sep 30 Oct 07 Oct 15 Oct 23
Open
$1.94
High
$2.01
Low
$1.94
Volume
$183,345
Avg Vol
$585,295
Mkt Cap
$69M
P/E (TTM)
0.66
Beta
—
52w High
$4.53
52w Low
$1.83
Div Yield
—
Shares Out
$33M

Recent Press Releases & News last 60 days · 1 item

Sep 8 · 12:00 PR GlobeNewswire
Fortress Biotech to Present at the H.C. Wainwright 28th Annual Global Investment Conference

FBIO earnings at a glance

The options market is pricing a move of about ±40.7% after the report, a range of roughly $1.16 to $2.74 from today's $1.95. Over its last 2 reports the stock rose the next day 2 times and fell 0, moving ±5.2% on average; after the most recent report on May 14, 2026 it moved +3.1%. That means options currently expect more movement than FBIO has typically delivered. FBIO beat the consensus EPS estimate in 1 of its last 3 reported quarters. Implied volatility is currently 344%. The share price of $1.95 sits near its 52-week low.

More Health Care stocks · All stocks · Earnings calendar

Overview

52-week range
$1.83
$4.53
4% of range
Avg surprise (last 3)
+22.7%
Avg reaction (last 2)
+5.2%
100% positive
Latest IV / EM
344%
EM ±40.7% · $3 · Oct 16

Earnings trends

EPS — actual vs estimate Actual Estimate
$-3.65$-2.03$-0.42$1.20$2.82 Actual $-0.21Actual $-3.65Actual $-0.94Actual $-1.04Actual $-0.73Actual $-0.76Actual $-0.48Est $-0.44Actual $-0.46Est $-0.31Actual $0.11Est $-0.43Actual $2.82Actual $-0.08 MarJunSepMarJunSepMar/2025Jun/2025Sep/2025Mar/2026Jun
Revenue vs Net Income Revenue Net income
$-13M$19M$52M$84M$116M Sep 24Mar 25Jun 25Sep 25Mar 26Jun 26

Earnings history

DatePeriodActual EPSEstSurpriseYoY %ΔDay reactSource
Tue Jun 30, 2026Jun 2026 $-0.08 — — — — financials
Thu May 14, 2026Mar/2026 $2.82 — — +687.5% +3.1% earnings
Fri Nov 14, 2025Sep/2025 $0.11 $-0.43 +125.6% — — earnings
Thu Aug 14, 2025Jun/2025 $-0.46 $-0.31 -48.4% — — earnings
Thu May 15, 2025Mar/2025 $-0.48 $-0.44 -9.1% — +7.2% earnings
Mon Sep 30, 2024Sep 2024 $-0.76 — — — — financials
Sun Jun 30, 2024Jun 2024 $-0.73 — — — — financials
Sun Mar 31, 2024Mar 2024 $-1.04 — — — — financials
Sat Sep 30, 2023Sep 2023 $-0.94 — — — — financials
Fri Jun 30, 2023Jun 2023 $-3.65 — — — — financials
Fri Mar 31, 2023Mar 2023 $-0.21 — — — — financials

Financials

Income statement (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Revenue$19M$16M—$18M$16M$13M—$15M
Cost of revenue$6M$6M—$6M$5M$5M—$4M
Gross profit————————
Operating income$-10M$-8M—$-7M$-36M$-22M—$-22M
Net income$-468,000$110M—$6M$15M$-11M—$-13M
EPS (diluted)$-0.08$2.82—$0.11$0.45$-0.48—$-0.76

Balance sheet (quarterly)

MetricJun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024
Cash & equivalents$197M$256M$79M$86M$74M$91M$57M$59M
Inventory$8M$9M$10M$12M$13M$12M$14M$12M
Total current assets$246M$295M$124M$119M$110M$127M$90M$86M
Total assets$317M$357M$186M$181M$160M$178M$144M$127M
Long-term debt$35M$38M$54M$48M$50M$56M—$52M
Total liabilities$111M$154M$123M$116M$123M$146M$146M$140M
Total equity$164M$202M$50M$56M$37M$32M$23M$-13M

Implied volatility — last 90 days

28%255%481%708%935% Jun 07 — IV 109% · EM ±15.1%Jun 08 — IV 126% · EM ±16.7%Jun 09 — IV 148% · EM ±18.6%Jun 10 — IV 244% · EM ±28.9%Jun 17 — IV 858% · EM ±35.8%Jun 19 — IV 98% · EM ±21.7%Jun 22 — IV 101% · EM ±21.1%Jun 23 — IV 201% · EM ±41.1%Jun 24 — IV 131% · EM ±26.2%Jun 25 — IV 211% · EM ±41.4%Jun 29 — IV 105% · EM ±18.6%Jun 30 — IV 147% · EM ±25.3%Jul 01 — IV 136% · EM ±22.7%Jul 02 — IV 203% · EM ±32.9%Jul 03 — IV 211% · EM ±32.9%Jul 06 — IV 37% · EM ±5.1%Jul 07 — IV 279% · EM ±36.8%Jul 08 — IV 279% · EM ±35.0%Jul 09 — IV 398% · EM ±47.0%Jul 10 — IV 287% · EM ±31.7%Jul 13 — IV 435% · EM ±36.4%Jul 14 — IV 835% · EM ±60.4%Jul 15 — IV 936% · EM ±55.3%Jul 16 — IV 700% · EM ±29.2%Jul 20 — IV 318% · EM ±75.1%Jul 21 — IV 238% · EM ±55.2%Jul 22 — IV 271% · EM ±62.0%Jul 23 — IV 713% · EM ±160.3%Jul 24 — IV 745% · EM ±164.7%Jul 27 — IV 322% · EM ±67.3%Jul 28 — IV 764% · EM ±156.3%Jul 29 — IV 805% · EM ±161.2%Jul 30 — IV 497% · EM ±97.3%Jul 31 — IV 326% · EM ±62.3%Aug 03 — IV 153% · EM ±27.1%Aug 04 — IV 183% · EM ±31.5%Aug 05 — IV 182% · EM ±30.5%Aug 06 — IV 190% · EM ±30.7%Aug 07 — IV 155% · EM ±24.2%Aug 10 — IV 131% · EM ±18.2%Aug 11 — IV 232% · EM ±30.7%Aug 12 — IV 230% · EM ±28.8%Aug 13 — IV 241% · EM ±28.5%Aug 18 — IV 333% · EM ±24.1%Aug 24 — IV 523% · EM ±109.2%Aug 25 — IV 164% · EM ±33.6%Aug 28 — IV 28% · EM ±5.4%Sep 02 — IV 197% · EM ±33.0%Sep 03 — IV 388% · EM ±62.7%Sep 04 — IV 261% · EM ±40.7%Sep 07 — IV 292% · EM ±40.4%Sep 21 — IV 70% · EM ±14.5%Sep 22 — IV 70% · EM ±14.3%Sep 23 — IV 85% · EM ±17.1%Sep 24 — IV 112% · EM ±21.9%Sep 25 — IV 115% · EM ±21.9%Sep 28 — IV 190% · EM ±33.6%Sep 29 — IV 185% · EM ±31.8%Sep 30 — IV 224% · EM ±37.4%Oct 01 — IV 269% · EM ±43.5%Oct 02 — IV 297% · EM ±46.3%Oct 06 — IV 332% · EM ±43.9%Oct 07 — IV 352% · EM ±44.1%Oct 08 — IV 344% · EM ±40.7%

Sector peers

CING
Cingulate Inc.
$69M $4.70+0.9%
CTOR
Citius Oncology, Inc.
$71M $0.66-5.6%
MAIA
MAIA Biotechnology, Inc.
$73M $1.14+0.1%
HRTX
Heron Therapeutics, Inc.
$73M $0.29-13.6%
LFVN
Lifevantage Corporation
$76M $5.61-5.7%
BOLD
Boundless Bio, Inc.
$60M $2.38-2.7%

FBIO earnings FAQ

What is FBIO's expected move for earnings?

Options currently price a move of about ±40.7%, or $0.79 per share either way from $1.95.

How does FBIO stock usually react to earnings?

Across the last 2 reports the average next-day move was ±5.2%, up 2 times and down 0 times.

What is FBIO's implied volatility?

FBIO's at-the-money implied volatility is about 344% based on the latest options snapshot.

View on Nasdaq ↗
🔒 Preview mode. Create a free account to unlock the full earnings calendar, all panels, heatmaps, options flow, and screener.
Sign up free → Sign in